You are here

mRNA-1345

FDA delays decision on Moderna's RSV shot until the end of May

Fierce Biotech

Fri, 05/10/24 - 11:44 am

Moderna Therapeutics

Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate

BioSpace

Mon, 01/30/23 - 10:37 am

Moderna Therapeutics

breakthrough therapy

Moderna advancing early stage mRNA prospects to show depth beyond COVID-19 shot

Fierce Biotech

Wed, 04/14/21 - 09:38 am

Moderna Therapeutics